185 related articles for article (PubMed ID: 19167889)
21. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
[TBL] [Abstract][Full Text] [Related]
22. Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients.
Beenakker EA; Maurits NM; Fock JM; Brouwer OF; van der Hoeven JH
Eur J Paediatr Neurol; 2005; 9(6):387-93. PubMed ID: 16102988
[TBL] [Abstract][Full Text] [Related]
23. What we do not know about pregnancy in hereditary neuromuscular disorders.
Argov Z; de Visser M
Neuromuscul Disord; 2009 Oct; 19(10):675-9. PubMed ID: 19692244
[TBL] [Abstract][Full Text] [Related]
24. Hand weakness in Duchenne muscular dystrophy and its relation to physical disability.
Mattar FL; Sobreira C
Neuromuscul Disord; 2008 Mar; 18(3):193-8. PubMed ID: 18207403
[TBL] [Abstract][Full Text] [Related]
25. The value of electromyography in the aetiological diagnosis of hypotonia in infants and toddlers.
Cetin E; Cuisset JM; Tiffreau V; Vallée L; Hurtevent JF; Thevenon A
Ann Phys Rehabil Med; 2009; 52(7-8):546-55. PubMed ID: 19713169
[TBL] [Abstract][Full Text] [Related]
26. [Validity of the motor function measurement scale when routinely used in the follow-up of adult outpatients in a neuromuscular center].
Benaïm C; Sacconi S; Fournier-Mehouas M; Tanant V; Desnuelle C
Rev Neurol (Paris); 2010 Jan; 166(1):49-53. PubMed ID: 19524275
[TBL] [Abstract][Full Text] [Related]
27. Value of immunohistochemical investigation in the diagnosis of neuromuscular diseases in children.
Matei D; Gherghina I; Cinteză E; Matei A; Alexianu M
Rom J Morphol Embryol; 2011; 52(1):111-5. PubMed ID: 21424041
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis of neuromuscular diseases.
Chance PF; Ashizawa T; Hoffman EP; Crawford TO
Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):49-81, vi. PubMed ID: 9894134
[TBL] [Abstract][Full Text] [Related]
29. Limb girdle muscular dystrophy: weakness and disease duration as predictors of functional impairment.
Stübgen JP; Lahouter A
Muscle Nerve; 1994 Aug; 17(8):873-80. PubMed ID: 8041394
[TBL] [Abstract][Full Text] [Related]
30. A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy.
Armand S; Mercier M; Watelain E; Patte K; Pelissier J; Rivier F
Gait Posture; 2005 Jun; 21(4):369-78. PubMed ID: 15886126
[TBL] [Abstract][Full Text] [Related]
31. [Clinical symptoms and disability of myotonic dystrophy in Japan].
Matsuoka Y; Saida K; Nishitani H; Takahashi A
No To Shinkei; 1988 Oct; 40(10):947-52. PubMed ID: 3196498
[TBL] [Abstract][Full Text] [Related]
32. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
Morrow JM; Sinclair CD; Fischmann A; Machado PM; Reilly MM; Yousry TA; Thornton JS; Hanna MG
Lancet Neurol; 2016 Jan; 15(1):65-77. PubMed ID: 26549782
[TBL] [Abstract][Full Text] [Related]
33. Relationships between motor impairments and activity limitations in patients with neuromuscular disorders.
Vandervelde L; Van den Bergh PY; Renders A; Goemans N; Thonnard JL
J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):326-32. PubMed ID: 18948363
[TBL] [Abstract][Full Text] [Related]
34. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.
Kalkman JS; Schillings ML; van der Werf SP; Padberg GW; Zwarts MJ; van Engelen BG; Bleijenberg G
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1406-9. PubMed ID: 16170086
[TBL] [Abstract][Full Text] [Related]
35. [Significance of electrophysiological examinations in the diagnosis of "frustrated" clinical forms of hereditary neuromuscular diseases].
Krstić S; Gospavić J; Vidaković Z
Neurologija; 1978; 26(1-4):129-33. PubMed ID: 754009
[No Abstract] [Full Text] [Related]
36. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease.
Van der Beek NA; Hagemans ML; Reuser AJ; Hop WC; Van der Ploeg AT; Van Doorn PA; Wokke JH
Neuromuscul Disord; 2009 Feb; 19(2):113-7. PubMed ID: 19084399
[TBL] [Abstract][Full Text] [Related]
37. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy.
Sveen ML; Thune JJ; Køber L; Vissing J
Arch Neurol; 2008 Sep; 65(9):1196-201. PubMed ID: 18779423
[TBL] [Abstract][Full Text] [Related]
38. Peak Cough Flow in Children with Neuromuscular Disorders.
Kotwal N; Shukla PJ; Perez GF
Lung; 2020 Apr; 198(2):371-375. PubMed ID: 32095889
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of late-onset Pompe disease: a prospective cohort study.
Wokke JH; Escolar DM; Pestronk A; Jaffe KM; Carter GT; van den Berg LH; Florence JM; Mayhew J; Skrinar A; Corzo D; Laforet P
Muscle Nerve; 2008 Oct; 38(4):1236-45. PubMed ID: 18816591
[TBL] [Abstract][Full Text] [Related]
40. Incidence of adaptive equipment use in subjects with a remote history of paralytic poliomyelitis.
Sorenson EJ; Windebank AJ
Neurology; 2005 Sep; 65(6):963. PubMed ID: 16186550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
